‌

US Patent 9415098 DNA vaccine for use in pancreatic cancer patients

Patent 9415098 was granted and assigned to Vaximm on August, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Heinz Lubenau0

Date of Patent

August 16, 2016

0

Patent Application Number

144094340

Date Filed

June 26, 2013

0

Patent Citations Received

US Patent 11779612 Engineered immunostimulatory bacterial strains and uses thereof

US Patent 12024709 Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment

0

Patent Primary Examiner

0

Patent abstract

The present invention relates to an attenuated mutant strain of Salmonella comprising a recombinant DNA molecule encoding a VEGF receptor protein. In particular, the present invention relate to the use of said attenuated mutant strain of Salmonella in cancer immunotherapy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9415098 DNA vaccine for use in pancreatic cancer patients

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.